HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx-Only Pseudoephedrine Legislation Spreads To More States

This article was originally published in The Tan Sheet

Executive Summary

Hawaii, Indiana, Kentucky and Virginia join the list of states considering legislation to require a prescription for all drugs containing pseudoephedrine.

You may also be interested in...



Tennessee Emerges As PSE Battleground With Rx, NPLEx Proposals

The conflict between electronic tracking of pseudoephedrine purchases and shifting the drug ingredient to prescription-only status is elevated in Tennessee as lawmakers offer bills for both anti-methamphetamine strategies.

In Brief

N.Y. rep to intro children's dosing bill

Missouri Looks Beyond Electronic Tracking To Rx-Only PSE In Meth Fight

Missouri's governor supports a prescription-only pseudoephedrine law, marking the latest state-level movement toward restricting access to the decongestant and precursor of methamphetamine.

Related Content

Topics

UsernamePublicRestriction

Register

RS134233

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel